A 60mg vial of Thymulin provides an ultra-high-mass format designed for large-scale bioassays, automated high-throughput screening, and longitudinal preclinical research models requiring consistent lot continuity. This technical guide outlines the physicochemical profile, precise reconstitution calculations, storage parameters, and quality control metrics for high-density Thymulin preparations.
A 60mg vial of Thymulin provides an ultra-high-mass format designed for large-scale bioassays, automated high-throughput screening, and longitudinal preclinical research models requiring consistent lot continuity. This technical guide outlines the physicochemical profile, precise reconstitution calculations, storage parameters, and quality control metrics for high-density Thymulin preparations.
A 60mg vial of Thymulin represents a bulk-quantity lyophilized peptide format tailored specifically for analytical laboratories, high-volume cell culture studies, and multi-animal preclinical cohorts. In high-throughput bioassays, utilizing a single high-mass vial reduces lot-to-lot variance and minimizes inter-assay noise caused by reconstitution differences across multiple smaller containers. Investigators utilizing this format typically perform automated liquid handling operations or continuous cellular exposure experiments where high stock concentrations are required.
Please note: PX1 Research primary catalog inventory currently features the standardized Thymulin 10mg vial size to ensure optimal stability and rapid reconstitution for standard lab workflows. For research teams requiring custom 60mg mass fills or bulk production runs, PX1 provides tailored synthesis and OEM fill options through our custom peptide synthesis program. You can explore our complete range of specialized research compounds across our all peptides catalog to identify the optimal format for your experimental design.
Every batch of Thymulin processed by PX1 Research undergoes rigorous analytical testing to verify sequence identity, purity, and freedom from bacterial contaminants. Regardless of whether a project requires standard 10mg vials or custom 60mg bulk configurations, every lot is supplied with a comprehensive, downloadable COA generated by an independent ISO 17025 accredited testing facility.
Thymulin (formerly referred to as serum thymic factor or FTS) is a naturally occurring thymic nonapeptide hormone with the amino acid sequence Pyr-Glu-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn. In its biologically active state, Thymulin strictly depends on an equimolar coordination complex with zinc (Zn2+). In vitro research demonstrates that the non-metallated form (des-zinc Thymulin) lacks biological activity in cellular signaling assays, whereas the zinc-bound nonapeptide induces conformational changes necessary for receptor interaction.
Preclinical studies suggest that Thymulin plays an integral role in immune system regulation, specifically guiding T-cell differentiation, modulating surface antigen expression (such as CD3, CD4, and CD8), and influencing cytokine secretion profiles in isolated splenocytes and thymocyte cultures. In vitro models evaluating thymic factor activity indicate that Thymulin activates intracellular cascade signaling through cyclic GMP (cGMP) pathway induction, serving as an important benchmark compound in cellular immunology research.
In addition to classical immunomodulatory pathways, neuroendocrine animal models suggest that Thymulin interacts with the hypothalamic-pituitary-adrenal (HPA) axis, modulating neuroinflammation and pain processing pathways in rodent models of inflammatory hyperalgesia. These diverse actions make high-purity Thymulin a valuable reference standard for investigate pathways governing neuro-immune cross-talk.
Reconstituting a 60mg mass vial requires careful volume planning due to the exceptionally high mass of peptide contained within standard 10mL laboratory vials. Because high peptide concentrations affect viscosity and dissolution dynamics, calculating precise mass-to-volume ratios is crucial prior to introducing diluents. Researchers can cross-reference calculations using our interactive reconstitution calculator to verify custom concentrations.
Below are standard concentration outputs achieved by reconstituting a 60mg Thymulin vial with common volumes of sterile laboratory diluent (such as Bacteriostatic Water, Sterile Water for Injection, or Phosphate-Buffered Saline at pH 7.4):
• 1.0 mL Diluent Volume: Yields a stock concentration of 60.0 mg/mL (60.0 µg/µL or 60,000 µg/mL). • 2.0 mL Diluent Volume: Yields a stock concentration of 30.0 mg/mL (30.0 µg/µL or 30,000 µg/mL). • 3.0 mL Diluent Volume: Yields a stock concentration of 20.0 mg/mL (20.0 µg/µL or 20,000 µg/mL). • 6.0 mL Diluent Volume: Yields a stock concentration of 10.0 mg/mL (10.0 µg/µL or 10,000 µg/mL). • 12.0 mL Diluent Volume: Yields a stock concentration of 5.0 mg/mL (5.0 µg/µL or 5,000 µg/mL).
When preparing working solutions from a 60mg stock, micro-pipetting accuracy is paramount. For example, if an in vitro assay protocol calls for a working concentration of 100 ng/mL in a 10 mL culture dish (1.0 µg total Thymulin), withdrawing exactly 0.05 µL from a 20 mg/mL stock is impractical and error-prone. Laboratory protocols must employ a two-step serial dilution scheme: first diluting the 20 mg/mL stock 1:100 in sterile PBS to create a 200 µg/mL intermediate stock, followed by further working-concentration dilutions into cell media.
Reconstituting a bulk 60mg vial without a clear aliquoting strategy risks compromising the peptide integrity through repeated freeze-thaw cycles. Freezing and thawing liquid peptide solutions induces physical shear stress, ice crystal formation, and localized pH shifts that promote peptide aggregation, peptide bond cleavage, and loss of zinc-coordination capacity.
To maximize stability following reconstitution, researchers should immediately partition the stock solution into single-use micro-aliquots using sterile, polypropylene, low-binding microcentrifuge tubes. For instance, reconstituting 60mg in 3.0 mL of diluent (20 mg/mL) allows for sixty 50 µL aliquots (1.0 mg Thymulin per tube) or one hundred twenty 25 µL aliquots (0.5 mg Thymulin per tube).
Once aliquoted, tubes intended for long-term storage must be immediately flash-frozen in liquid nitrogen or an ultra-low temperature freezer (-80°C). Working aliquots required for immediate use within 48 to 72 hours may be maintained at 2°C to 8°C. Never return a thawed aliquot back to frozen storage; discarded residual volumes preserve inter-assay consistency and remove experimental variables.
Because Thymulin is frequently employed in delicate immune cell cultures and sensitive primary thymocyte assays, strict quality control is non-negotiable. Contaminants such as residual TFA (trifluoroacetic acid), heavy metals, or bacterial endotoxins can confound cell viability metrics, induce non-specific toll-like receptor (TLR) activation, and skew cytokine baseline measurements.
PX1 Research enforces rigorous analytical oversight for all synthesized peptide lots. Every production run undergoes High-Performance Liquid Chromatography (HPLC) coupled with UV detection to confirm chemical purity exceeds standard research thresholds (≥98.0%). Electrospray Ionization Mass Spectrometry (ESI-MS) is simultaneously performed to verify the exact molecular mass (1057.18 Da) and ensure the absence of truncated synthesis byproducts or residual protecting groups.
Furthermore, because bacterial lipopolysaccharide (LPS) contamination directly activates macrophages and T-cells—confounding T-cell differentiation assays—PX1 subjects all lots to chromogenic Limulus Amebocyte Lysate (LAL) testing. Our endotoxin specification guarantees <0.01 EU/mg, protecting cell cultures from artifactual inflammatory responses. Detailed certificates outlining HPLC chromatograms, mass spectra, and endotoxin values are available via our central COA database.
In cellular immunology and peptide hormone research, investigators frequently compare Thymulin against other thymic-derived signaling molecules to map distinct pathways of lymphocyte maturation and tissue repair. Selecting the correct biological reference compound depends on the specific receptor system or functional output under evaluation.
Preclinical studies highlight clear structural and functional differences among primary thymic peptides:
• Thymosin Alpha-1: A 28-amino acid peptide derived from Prothymosin Alpha. Investigated extensively for its capacity to stimulate TLR3/TLR9 pathways, enhance major histocompatibility complex (MHC) Class I expression, and promote mature T-cell signal transduction. • Thymosin Beta-4: A 43-amino acid G-actin sequestering peptide studied primarily for cell migration, focal adhesion formation, angiogenesis, and tissue repair models rather than direct T-cell differentiation. • Thymopentin: A synthetic pentapeptide (Arg-Lys-Asp-Val-Tyr) representing the active site (residues 32–36) of Thymopoietin. Investigated for phenotypic induction of early T-lymphocyte precursors without requiring metal coordination.
Unlike Thymopentin or Thymosin Alpha-1, Thymulin’s absolute dependence on zinc coordination provides a unique experimental probe for studying metal-dependent hormone activity and trace element modulation in immune signaling cascades.
Determining whether a laboratory should source high-mass 60mg custom fills or standard 10mg Thymulin vials depends primarily on experimental scale, liquid handling capabilities, and project duration.
Standard 10mg vials represent the optimal choice for pilot studies, exploratory in vitro assays, and laboratories without access to automated micro-aliquoting equipment. A 10mg format minimizes the time reconstituted liquid remains in storage, reduces the risk of accidental room-temperature exposure, and allows researchers to refresh stock solutions frequently.
Conversely, a 60mg custom fill format is advantageous for continuous, high-throughput screening campaigns, automated robotic pipetting platforms, or multi-animal longitudinal studies spanning several months. Sourcing a single 60mg batch ensures that thousands of assay wells or extensive animal treatment groups receive compound from an identical synthesis lot, eliminating batch-to-batch variations in counter-ion content or minor impurities. Laboratories considering bulk research configurations for ongoing institutional projects can coordinate through our dedicated PX1 Wholesale department.
Executing a clean reconstitution of high-mass 60mg Thymulin requires aseptic laboratory techniques and appropriate solvent selection. Follow this general laboratory protocol to prepare stock solutions:
1. Preparation: Remove the lyophilized vial from cold storage (-20°C) and allow it to equilibrate to room temperature (20°C–25°C) inside a laminar flow hood for 30 minutes. This prevents condensation from forming inside the vial upon opening. 2. Surface Decontamination: Sanitize the rubber septum with a 70% isopropyl alcohol wipe and allow it to air-dry completely. 3. Diluent Addition: Using a calibrated micropipette or sterile syringe, draw the calculated volume of sterile diluent (e.g., Bacteriostatic Water containing 0.9% benzyl alcohol or sterile 0.9% NaCl). Direct the liquid stream slowly down the glass inner wall of the vial rather than shooting it directly onto the lyophilized cake. 4. Dissolution: Gently swirl the vial in a circular motion. Do not vortex vigorously, as aggressive mechanical agitation introduces shear stress and forms foam, which can denature the peptide structure. Allow 3 to 5 minutes for complete visual clarity. 5. Inspection: Inspect the reconstituted solution under direct light. The solution should be completely clear, colorless, and free of visible particulates or undissolved flakes.
For additional guidance on adjusting concentrations or calculating working dilutions across various solvent systems, access our technical tools via the PX1 Research Hub.
Lyophilized Thymulin powder exhibits excellent physical stability when stored under controlled environment conditions. Sealed vials received from PX1 Research should be stored at -20°C in a desiccated freezer compartment protected from light exposure. Under these conditions, the un-reconstituted powder maintains specification compliance for up to 24 months from the manufacturing date.
Once reconstituted, the chemical stability of Thymulin liquid stock depends heavily on solvent selection and temperature control:
• Reconstituted in Sterile Water / PBS (2°C to 8°C): Stable for up to 7 days. Ideal for immediate short-term assays. • Reconstituted in Bacteriostatic Water (2°C to 8°C): Preserved against bacterial proliferation for up to 28 days due to the presence of 0.9% benzyl alcohol. • Reconstituted Aliquots (-80°C Ultra-Low Freezer): Stable for up to 6 months. Micro-aliquots must be protected from ambient light and kept in airtight storage boxes to prevent frost sublimation.
Never subject reconstituted Thymulin solutions to frost-free residential freezers, as their automated temperature cycling causes localized thawing and rapid degradation of peptide bonds.
PX1 Research operates dedicated, state-of-the-art laboratory facilities located in California and Arizona. All peptide manufacturing and custom filling procedures adhere strictly to Good Manufacturing Practice (GMP) standards, ensuring exceptional consistency and batch traceability.
Orders placed before 12:00 PM PST Monday through Friday ship same-day via expedited courier services from our domestic fulfillment hubs. Fast domestic shipping prevents extended temperature excursions during transit, ensuring that lyophilized products arrive at your institution maintaining maximum biochemical integrity.
Whether your team requires standard catalog items like our Thymulin 10mg vials or requires specialized, bulk manufacturing runs, PX1 provides transparent lot documentation, responsive customer support, and uncompromised quality standards for the global scientific community.
What is the primary physical state of a 60mg Thymulin vial upon delivery?
Thymulin is supplied as a sterile, lyophilized (freeze-dried) white powder or cake contained in a vacuum-sealed glass vial to ensure maximum chemical stability during storage and transit.
Does PX1 Research currently stock 60mg Thymulin vials directly in the catalog?
PX1 Research maintains standard catalog inventory of Thymulin in 10mg vial sizes. High-mass formats such as 60mg are manufactured via custom synthesis and specialized bulk fill services for high-volume laboratory accounts.
Why is zinc coordination necessary when researching Thymulin?
In vitro research shows that Thymulin strictly requires stoichiometric coordination with zinc (Zn2+) to achieve its biologically active conformation. Without zinc, the des-zinc nonapeptide fails to induce target T-cell receptor pathways.
How much diluent should be added to a 60mg vial to yield a 10 mg/mL concentration?
Reconstituting a 60mg vial with exactly 6.0 mL of sterile diluent produces a stock concentration of 10 mg/mL (10 µg/µL).
Can reconstituted Thymulin be repeatedly frozen and thawed?
No. Repeated freeze-thaw cycles cause physical shear stress, peptide aggregation, and functional loss of zinc binding. Reconstituted stock should be divided into single-use aliquots and frozen at -80°C.
What are the endotoxin limits for PX1 Research Thymulin lots?
Every lot of Thymulin manufactured by PX1 is tested via LAL chromogenic assay and certified to contain <0.01 EU/mg, preventing non-specific immune activation in primary cell assays.
How can researchers verify the purity of their specific batch?
Every order includes a lot-matched Certificate of Analysis (COA) detailing HPLC purity profiles (≥98%) and ESI-MS mass verification, accessible directly through our online COA portal.
Is Thymulin intended or approved for human or veterinary administration?
No. All products supplied by PX1 Research, including Thymulin, are strictly manufactured for in vitro, cellular, and preclinical laboratory research use only. They are never for human or veterinary administration, medical treatment, or clinical diagnostics.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.